For example, IL-6 can inhibit the tyrosine phosphorylation of insulin receptor substrates (IRS) by activating signal transduction proteins and transcriptional activators (STAT) and other pathways, blocking the transmission of insulin signals to the downstream, making insulin resistance more serious and blood sugar difficult to control. This evidence concerns the gene INS and Insulin resistance.